ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721 | -78.9% | 26,840 | -71.9% | 0.00% | -75.0% |
| Q2 2023 | $3,411 | +369.8% | 95,660 | +234.7% | 0.01% | +300.0% |
| Q1 2023 | $726 | -36.5% | 28,584 | +1.4% | 0.00% | -33.3% |
| Q4 2022 | $1,144 | -99.9% | 28,194 | +0.6% | 0.00% | 0.0% |
| Q3 2022 | $926,000 | -5.2% | 28,015 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $977,000 | -22.9% | 27,740 | +0.7% | 0.00% | +50.0% |
| Q1 2022 | $1,267,000 | -58.4% | 27,558 | -34.7% | 0.00% | -66.7% |
| Q4 2021 | $3,043,000 | +16.1% | 42,218 | +0.6% | 0.01% | +20.0% |
| Q3 2021 | $2,620,000 | -25.3% | 41,980 | -0.9% | 0.01% | -28.6% |
| Q2 2021 | $3,508,000 | -51.7% | 42,359 | -61.3% | 0.01% | -56.2% |
| Q1 2021 | $7,257,000 | -19.3% | 109,434 | -6.6% | 0.02% | -23.8% |
| Q4 2020 | $8,988,000 | +393.8% | 117,135 | +177.1% | 0.02% | +320.0% |
| Q3 2020 | $1,820,000 | +49.9% | 42,268 | +50.3% | 0.01% | +25.0% |
| Q2 2020 | $1,214,000 | +61.2% | 28,114 | +7.5% | 0.00% | +33.3% |
| Q1 2020 | $753,000 | -54.6% | 26,157 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $1,659,000 | -22.2% | 26,157 | -65.4% | 0.01% | -28.6% |
| Q3 2019 | $2,132,000 | +8.9% | 75,659 | +2.4% | 0.01% | +16.7% |
| Q2 2019 | $1,958,000 | – | 73,903 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |